FT
FTAIN
FTAI Aviation Ltd.
$24.99
+0.04%
$2.6B
No data for this timeframe.
Vol
Market Cap$2.6B
Cap SizeMid Cap
SEC Reports4
Exchange Nasdaq·Sector Services-Miscellaneous Equipment Rental & Leasing·CIK 0001590364·Prev Close $24.98
Recent Activity
May 1, 2026
SEC
FTAI Aviation filed an automatic shelf registration (S-3ASR) to potentially offer various securities, including common a
S-3ASR — Impact 3/10
May 1, 2026
SEC
Director Martin Tuchman filed a Form 144 indicating intent to sell 143,584 shares valued at approximately $34.8 million,
144 — Impact 5/10
Apr 30, 2026
SEC
FTAI Aviation upsized its revolving credit facility from $400M to $2.025B, extending maturity to April 2031 with improve
8-K — Impact 5/10
Analyst Ratings
6Strong Buy
10Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
S-3ASR
3/10
FTAI Aviation filed an automatic shelf registration (S-3ASR) to potentially offer various securities, including common a
May 1, 2026
MIXED
144
5/10
Director Martin Tuchman filed a Form 144 indicating intent to sell 143,584 shares valued at approximately $34.8 million,
May 1, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 1 mixed, 2 neutral. Avg impact: 5.0/10.
NEUTRAL
S-3ASR
3/10
FTAI Aviation filed an automatic shelf registration (S-3ASR) to potentially offer various securities
May 1, 2026
MIXED
144
5/10
Director Martin Tuchman filed a Form 144 indicating intent to sell 143,584 shares valued at approxim
May 1, 2026
NEUTRAL
8-K
5/10
FTAI Aviation upsized its revolving credit facility from $400M to $2.025B, extending maturity to Apr
Apr 30, 2026
BULLISH
8-K
7/10
FTAI Aviation reported Q1 2026 revenue of $830.7M, beating consensus of $733.5M by 13.2%, with dilut
Apr 29, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 94% buy across 17 analysts — 6 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.9B | 26.9% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.9B | 36.6% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $3.5B | 41.4% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $5.1B | 42.7% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 10 | 1 | 0 | 0 | 94% | |
| May 1, 2026 | 6 | 10 | 1 | 0 | 0 | 94% | |
| Apr 1, 2026 | 6 | 10 | 1 | 0 | 0 | 94% | |
| Mar 1, 2026 | 6 | 10 | 1 | 0 | 0 | 94% | |
| Feb 1, 2026 | 6 | 10 | 1 | 0 | 0 | 94% | |
| Jan 1, 2026 | 6 | 10 | 1 | 0 | 0 | 94% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.